Metoprololo Aurobindo (Metoprolol Tartrate)

Metoprolol is indicated for several cardiovascular conditions that involve elevated blood pressure or cardiac workload.

• Hypertension: reduces systolic and diastolic blood pressure, helping to prevent stroke and organ damage.
• Angina pectoris: decreases myocardial oxygen demand, relieving chest pain episodes.
• Heart failure: improves left ventricular function and reduces hospitalization risk.
• Cardiac arrhythmias: controls heart rate in supraventricular tachycardia and atrial fibrillation.

• Metoprolol selectively blocks β1‑adrenergic receptors in the heart, inhibiting the effects of endogenous catecholamines such as norepinephrine. This antagonism lowers heart rate, reduces myocardial contractility, and diminishes cardiac output, leading to decreased oxygen consumption and blood pressure. The selectivity spares β2 receptors in the lungs, minimizing bronchial effects compared with non‑selective beta blockers. By attenuating sympathetic stimulation, metoprolol also contributes to improved ventricular filling and stabilizes abnormal rhythm generation.

Metoprolol may cause a range of adverse reactions, from mild to serious, that should be monitored during therapy.

Common Side Effects

• Fatigue or tiredness
• Dizziness or light‑headedness
• Cold extremities, especially hands and feet
• Gastrointestinal upset such as nausea or abdominal discomfort
• Mild depression or mood changes

Serious or Rare Side Effects

• Bradycardia or excessively low heart rate
• Severe hypotension leading to fainting
• Congestive heart failure exacerbation
• Bronchospasm in patients with asthma or COPD
• Allergic reactions including rash, itching, or angio‑edema

Before initiating metoprolol therapy, clinicians should consider several precautionary measures to ensure patient safety.

• Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension.
• Heart rate assessment: evaluate resting pulse and adjust dose if bradycardia develops.
• Respiratory caution: use carefully in patients with asthma or chronic obstructive pulmonary disease.
• Renal or hepatic impairment: consider dose reduction and monitor organ function.
• Drug discontinuation: taper gradually rather than abrupt cessation to prevent rebound tachycardia.
• Store at room temperature: keep tablets in the original container, protect from moisture and direct sunlight.

Metoprolol can interact with other medicines, altering its effectiveness or increasing risk of adverse events.

Major Interactions (Avoid)

• Non‑selective beta blockers: combined use may cause profound bradycardia and hypotension.
• Calcium channel blockers (verapamil, diltiazem): increase plasma levels of metoprolol, leading to excessive cardiac depression.
• Insulin or oral hypoglycemics: may mask hypoglycemia symptoms, requiring glucose monitoring.
• MAO inhibitors: can enhance antihypertensive effects and cause severe hypotension.

Moderate Interactions (Monitor Closely)

• Diuretics: may amplify blood pressure lowering, necessitating electrolyte and pressure checks.
• NSAIDs: can reduce antihypertensive efficacy of metoprolol.
• Digoxin: concurrent use may increase risk of bradyarrhythmias.
• Antidepressants (SSRIs): may modestly raise metoprolol concentrations.